Oscar Health raises 2026 guidance, shares rise
Oscar Health lifted its full-year 2026 earnings from operations target to $600 million-$800 million from $500 million-$700 million and trimmed its medical loss ratio outlook to 81.0%-82.0%. Analysts also raised price targets after the company’s Investor Day presentation.